SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 9.09 |
| Enterprise Value ($M) | -7.30 |
| Book Value ($M) | 13.16 |
| Book Value / Share | 4.18 |
| Price / Book | 0.69 |
| NCAV ($M) | 2.07 |
| NCAV / Share | 0.66 |
| Price / NCAV | 4.39 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.99 |
| Return on Assets (ROA) | -0.48 |
| Return on Equity (ROE) | -1.18 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.95 |
| Current Ratio | 3.32 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 23.98 |
| Assets | 35.07 |
| Liabilities | 21.91 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 9.59 |
| Operating Income | -9.94 |
| Net Income | -15.31 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -14.57 |
| Cash from Investing | 25.08 |
| Cash from Financing | -0.59 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Goodwood Inc. | 8.20 | 16.11 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 93 | 1,449 | 6.42 | |
| 441 | 3,445 | 12.80 | |
| 759 | 1,602 | 47.38 | |
| 764 | 1,579 | 48.39 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRIS – Curis, Inc. | CRVO – CervoMed Inc. |
| CSBR – Champions Oncology, Inc. | CTXR – Citius Pharmaceuticals, Inc. |
| CUE – Cue Biopharma, Inc. |
Financial data and stock pages provided by
Fintel.io